series-a
Stage
2018
Founded
1
Investors
About
A clinical-stage biotechnology company developing life-changing gene therapies for prevalent musculoskeletal diseases like osteoarthritis.
Explore Genascence's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.